Equities

Pro Medicus Ltd

Pro Medicus Ltd

Actions
  • Price (USD)124.22
  • Today's Change0.00 / 0.00%
  • Shares traded52.00
  • 1 Year change+134.38%
  • Beta--
Data delayed at least 15 minutes, as of Nov 12 2024 17:59 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Balance sheet Back to Overview

In millions of AUD
(except for per share items)
Fiscal data as of Jun 30 2024202420232022
ASSETS
Cash And Short Term Investments15312091
Total Receivables, Net494128
Total Inventory0.050.060.08
Prepaid expenses1.891.581.30
Other current assets, total1.991.10--
Total current assets207164120
Property, plant & equipment, net2.382.192.60
Goodwill, net------
Intangibles, net202122
Long term investments7.34----
Note receivable - long term3.862.361.47
Other long term assets------
Total assets257202157
LIABILITIES
Accounts payable1.741.031.64
Accrued expenses4.353.752.98
Notes payable/short-term debt000
Current portion long-term debt/capital leases0.550.650.60
Other current liabilities, total282522
Total current liabilities353127
Total long term debt1.521.201.68
Total debt2.071.852.28
Deferred income tax7.667.818.09
Minority interest------
Other liabilities, total262319
Total liabilities706355
SHAREHOLDERS EQUITY
Common stock241.961.96
Additional paid-in capital------
Retained earnings (accumulated deficit)165137101
Treasury stock - common------
Unrealized gain (loss)------
Other equity, total(0.91)(0.68)(0.84)
Total equity188139102
Total liabilities & shareholders' equity257202157
Total common shares outstanding104104104
Treasury shares - common primary issue000
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.